Zhaoting Zhang, Lei Geng, Jiuxin Gao, Ruifang She, Zhonglin Ge, Jianhua Liu, Qianqian He, Bing Fu, Weiguo Liu
{"title":"Association between <i>LRRK2</i> gene polymorphisms and Parkinson's disease progression in a Chinese Han population.","authors":"Zhaoting Zhang, Lei Geng, Jiuxin Gao, Ruifang She, Zhonglin Ge, Jianhua Liu, Qianqian He, Bing Fu, Weiguo Liu","doi":"10.3389/fgene.2025.1662348","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study was to investigate the association between <i>LRRK2</i> gene polymorphisms and Parkinson's disease (PD) risk, as well as the progression of PD, in a Chinese Han population.</p><p><strong>Methods: </strong>A case-control study was carried out on 180 PD patients and 196 healthy controls between October 2019 and October 2023. The demographic and clinical data of all participants were collected. At the baseline and 3-year follow-up, assessment of motor and non-motor symptoms of PD patients were carried out using scales including Unified Parkinson's Disease Rating Scale parts II, III, and IV, Hoehn and Yahr (H-Y) staging scale, Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale, Non-motor Symptom Questionnaire, Parkinson's disease sleep scale, Montreal Cognitive Assessment, and Mini-Mental State Examination. Six single nucleotide polymorphisms (SNPs) of the <i>LRRK2</i> gene rs1994090, rs2046932, rs2708453, rs34778348, rs4768212, and rs7304279 were selected and genotyped using the MassARRAY platform in all participants.</p><p><strong>Results: </strong>A strong linkage disequilibrium was observed among the five SNP loci of the <i>LRRK2</i> gene, including rs1994090, rs2046932, rs2708453, rs4768212, and rs7304279. <i>LRRK2</i> rs7304279 (OR = 3.572, P < 0.001) and rs34778348 (OR = 0.408, P = 0.003) contributed to the risk of PD development. Carriage of more risk variants were associated with higher risk of PD (OR = 6.467, P < 0.001). Cox proportional hazards model analysis showed that <i>LRRK2</i> rs7304279 polymorphism was significantly associated with H-Y stage progression (<i>P</i> = 0.030).</p><p><strong>Conclusion: </strong>Our findings suggest that <i>LRRK2</i> rs34778348 and rs7304279 polymorphisms are associated with the risk of developing PD. And <i>LRRK2</i> rs7304279 polymorphism is correlated with disease progression in PD patients.</p>","PeriodicalId":12750,"journal":{"name":"Frontiers in Genetics","volume":"16 ","pages":"1662348"},"PeriodicalIF":2.8000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12507364/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Genetics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.3389/fgene.2025.1662348","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The objective of this study was to investigate the association between LRRK2 gene polymorphisms and Parkinson's disease (PD) risk, as well as the progression of PD, in a Chinese Han population.
Methods: A case-control study was carried out on 180 PD patients and 196 healthy controls between October 2019 and October 2023. The demographic and clinical data of all participants were collected. At the baseline and 3-year follow-up, assessment of motor and non-motor symptoms of PD patients were carried out using scales including Unified Parkinson's Disease Rating Scale parts II, III, and IV, Hoehn and Yahr (H-Y) staging scale, Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale, Non-motor Symptom Questionnaire, Parkinson's disease sleep scale, Montreal Cognitive Assessment, and Mini-Mental State Examination. Six single nucleotide polymorphisms (SNPs) of the LRRK2 gene rs1994090, rs2046932, rs2708453, rs34778348, rs4768212, and rs7304279 were selected and genotyped using the MassARRAY platform in all participants.
Results: A strong linkage disequilibrium was observed among the five SNP loci of the LRRK2 gene, including rs1994090, rs2046932, rs2708453, rs4768212, and rs7304279. LRRK2 rs7304279 (OR = 3.572, P < 0.001) and rs34778348 (OR = 0.408, P = 0.003) contributed to the risk of PD development. Carriage of more risk variants were associated with higher risk of PD (OR = 6.467, P < 0.001). Cox proportional hazards model analysis showed that LRRK2 rs7304279 polymorphism was significantly associated with H-Y stage progression (P = 0.030).
Conclusion: Our findings suggest that LRRK2 rs34778348 and rs7304279 polymorphisms are associated with the risk of developing PD. And LRRK2 rs7304279 polymorphism is correlated with disease progression in PD patients.
Frontiers in GeneticsBiochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
5.50
自引率
8.10%
发文量
3491
审稿时长
14 weeks
期刊介绍:
Frontiers in Genetics publishes rigorously peer-reviewed research on genes and genomes relating to all the domains of life, from humans to plants to livestock and other model organisms. Led by an outstanding Editorial Board of the world’s leading experts, this multidisciplinary, open-access journal is at the forefront of communicating cutting-edge research to researchers, academics, clinicians, policy makers and the public.
The study of inheritance and the impact of the genome on various biological processes is well documented. However, the majority of discoveries are still to come. A new era is seeing major developments in the function and variability of the genome, the use of genetic and genomic tools and the analysis of the genetic basis of various biological phenomena.